152 related articles for article (PubMed ID: 11306106)
21. Tryptophan in alcoholism treatment II: inhibition of the rat liver mitochondrial low Km aldehyde dehydrogenase activity, elevation of blood acetaldehyde concentration and induction of aversion to alcohol by combined administration of tryptophan and benserazide.
Badawy AA; Bano S; Steptoe A
Alcohol Alcohol; 2011; 46(6):661-71. PubMed ID: 21896551
[TBL] [Abstract][Full Text] [Related]
22. Isoflavonoid compounds extracted from Pueraria lobata suppress alcohol preference in a pharmacogenetic rat model of alcoholism.
Lin RC; Guthrie S; Xie CY; Mai K; Lee DY; Lumeng L; Li TK
Alcohol Clin Exp Res; 1996 Jun; 20(4):659-63. PubMed ID: 8800381
[TBL] [Abstract][Full Text] [Related]
23. Behavioral effects of phenelzine in an experimental model for screening anxiolytic and anti-panic drugs: correlation with changes in monoamine-oxidase activity and monoamine levels.
Griebel G; Curet O; Perrault G; Sanger DJ
Neuropharmacology; 1998 Jul; 37(7):927-35. PubMed ID: 9776388
[TBL] [Abstract][Full Text] [Related]
24. Daidzin: a potent, selective inhibitor of human mitochondrial aldehyde dehydrogenase.
Keung WM; Vallee BL
Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1247-51. PubMed ID: 8433985
[TBL] [Abstract][Full Text] [Related]
25. Structure of daidzin, a naturally occurring anti-alcohol-addiction agent, in complex with human mitochondrial aldehyde dehydrogenase.
Lowe ED; Gao GY; Johnson LN; Keung WM
J Med Chem; 2008 Aug; 51(15):4482-7. PubMed ID: 18613661
[TBL] [Abstract][Full Text] [Related]
26. Daidzin and daidzein suppress free-choice ethanol intake by Syrian golden hamsters.
Keung WM; Vallee BL
Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10008-12. PubMed ID: 8234248
[TBL] [Abstract][Full Text] [Related]
27. Metabolism of biogenic aldehydes in isolated human blood cells, platelets and in plasma.
Helander A; Tottmar O
Biochem Pharmacol; 1987 Apr; 36(7):1077-82. PubMed ID: 2436624
[TBL] [Abstract][Full Text] [Related]
28. Brain dialysis: in vivo metabolism of dopamine and serotonin by monoamine oxidase A but not B in the striatum of unrestrained rats.
Kato T; Dong B; Ishii K; Kinemuchi H
J Neurochem; 1986 Apr; 46(4):1277-82. PubMed ID: 2419508
[TBL] [Abstract][Full Text] [Related]
29. Products of oxidative stress inhibit aldehyde oxidation and reduction pathways in dopamine catabolism yielding elevated levels of a reactive intermediate.
Jinsmaa Y; Florang VR; Rees JN; Anderson DG; Strack S; Doorn JA
Chem Res Toxicol; 2009 May; 22(5):835-41. PubMed ID: 19388687
[TBL] [Abstract][Full Text] [Related]
30. Tryptophan in alcoholism treatment I: kynurenine metabolites inhibit the rat liver mitochondrial low Km aldehyde dehydrogenase activity, elevate blood acetaldehyde concentration and induce aversion to alcohol.
Badawy AA; Bano S; Steptoe A
Alcohol Alcohol; 2011; 46(6):651-60. PubMed ID: 21896552
[TBL] [Abstract][Full Text] [Related]
31. Lipid peroxidation products inhibit dopamine catabolism yielding aberrant levels of a reactive intermediate.
Rees JN; Florang VR; Anderson DG; Doorn JA
Chem Res Toxicol; 2007 Oct; 20(10):1536-42. PubMed ID: 17887726
[TBL] [Abstract][Full Text] [Related]
32. 3,4-Dihydroxyphenylethanol (Hydroxytyrosol) Mitigates the Increase in Spontaneous Oxidation of Dopamine During Monoamine Oxidase Inhibition in PC12 Cells.
Goldstein DS; Jinsmaa Y; Sullivan P; Holmes C; Kopin IJ; Sharabi Y
Neurochem Res; 2016 Sep; 41(9):2173-8. PubMed ID: 27220335
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of the oxidative metabolism of 3,4-dihydroxyphenylacetaldehyde, a reactive intermediate of dopamine metabolism, by 4-hydroxy-2-nonenal.
Florang VR; Rees JN; Brogden NK; Anderson DG; Hurley TD; Doorn JA
Neurotoxicology; 2007 Jan; 28(1):76-82. PubMed ID: 16956664
[TBL] [Abstract][Full Text] [Related]
34. SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
Aubin N; Barneoud P; Carter C; Caille D; Sontag N; Marc C; Lolivier J; Gardes A; Perron C; Le Kim A; Charieras T; Pandini M; Burnier P; Puech F; Jegham S; George P; Scatton B; Curet O
J Pharmacol Exp Ther; 2004 Sep; 310(3):1171-82. PubMed ID: 15178694
[TBL] [Abstract][Full Text] [Related]
35. Identification of kaempferol as a monoamine oxidase inhibitor and potential Neuroprotectant in extracts of Ginkgo biloba leaves.
Sloley BD; Urichuk LJ; Morley P; Durkin J; Shan JJ; Pang PK; Coutts RT
J Pharm Pharmacol; 2000 Apr; 52(4):451-9. PubMed ID: 10813558
[TBL] [Abstract][Full Text] [Related]
36. Reversibility of the interaction of CGP 11305 A with MAO A in vivo.
Waldmeier PC; Feldtrauer JJ; Stoecklin K; Paul E
Eur J Pharmacol; 1983 Oct; 94(1-2):101-8. PubMed ID: 6197309
[TBL] [Abstract][Full Text] [Related]
37. The Catecholaldehyde Hypothesis for the Pathogenesis of Catecholaminergic Neurodegeneration: What We Know and What We Do Not Know.
Goldstein DS
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34206133
[TBL] [Abstract][Full Text] [Related]
38. Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson's disease.
Goldstein DS; Sullivan P; Holmes C; Miller GW; Alter S; Strong R; Mash DC; Kopin IJ; Sharabi Y
J Neurochem; 2013 Sep; 126(5):591-603. PubMed ID: 23786406
[TBL] [Abstract][Full Text] [Related]
39. The effect of N-methyl-norsalsolinol on monoamine oxidase of the rat caudate nucleus in vitro.
Moser A; Scholz J; Bamberg H; Böhme V
Neurochem Int; 1996 Jan; 28(1):109-12. PubMed ID: 8746770
[TBL] [Abstract][Full Text] [Related]
40. Effects of ethanol, acetaldehyde and disulfiram on the metabolism of biogenic aldehydes in isolated human blood cells and platelets.
Helander A; Tottmar O
Biochem Pharmacol; 1987 Nov; 36(22):3981-5. PubMed ID: 2446627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
